Refinement of the prognostic impact of somatic CEBPA bZIP domain mutations in acute myeloid leukemia: Results of the AML Study Group (AMLSG)
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
HemaSphere. - 8, 7 (2024) , e123, ISSN: 2572-9241
- Event
-
Veröffentlichung
- (where)
-
Freiburg
- (who)
-
Universität
- (when)
-
2024
- Creator
- DOI
-
10.1002/hem3.123
- URN
-
urn:nbn:de:bsz:25-freidok-2558643
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
25.03.2025, 1:48 PM CET
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Rücker, Frank Gert
- Corbacioglu, Andrea
- Lübbert, Michael
- Döhner, Konstanze
- Universität
Time of origin
- 2024
Other Objects (12)
Molekulare Mechanismen der normalen myeloischen Differenzierung und ihrer Störung bei akuten myeloischen Leukämien
MDS und akute myeloische Leukämie : ein biologisches und therapeutisches Kontinuum
Myelodysplastic syndromes and acute myeloid leukemia : a biological and therapeutic continuum
Epigenetic therapy of cancer : preclinical models and treatment approaches
Elucidation of a hypersplicing phenotype in SRSF2 mutant myeloid malignancy
DNA-Methylierungssignaturen bei älteren Patienten mit akuter myeloischer Leukämie
Charakterisierung der antileukämischen Aktivität von drei Hydroxamat-Histondesacetylase-Inhibitoren
AML1/ETO and its function as a regulator of gene transcription via epigenetic mechanisms
Impact of pretreatment characteristics and salvage strategy on outcome in patients with relapsed acute myeloid leukemia
Condensed versus standard schedule of high-dose cytarabine consolidation therapy with pegfilgrastim growth factor support in acute myeloid leukemia
The new WHO 2022 and ICC proposals for the classification of myelodysplastic neoplasms. Validation based on the Düsseldorf MDS Registry and proposals for a merged classification
Clinical results of hypomethylating agents in AML treatment
Molekulare Mechanismen der normalen myeloischen Differenzierung und ihrer Störung bei akuten myeloischen Leukämien
MDS und akute myeloische Leukämie : ein biologisches und therapeutisches Kontinuum
Myelodysplastic syndromes and acute myeloid leukemia : a biological and therapeutic continuum
Epigenetic therapy of cancer : preclinical models and treatment approaches
Elucidation of a hypersplicing phenotype in SRSF2 mutant myeloid malignancy
DNA-Methylierungssignaturen bei älteren Patienten mit akuter myeloischer Leukämie
Charakterisierung der antileukämischen Aktivität von drei Hydroxamat-Histondesacetylase-Inhibitoren
AML1/ETO and its function as a regulator of gene transcription via epigenetic mechanisms
Impact of pretreatment characteristics and salvage strategy on outcome in patients with relapsed acute myeloid leukemia
Condensed versus standard schedule of high-dose cytarabine consolidation therapy with pegfilgrastim growth factor support in acute myeloid leukemia
The new WHO 2022 and ICC proposals for the classification of myelodysplastic neoplasms. Validation based on the Düsseldorf MDS Registry and proposals for a merged classification
Clinical results of hypomethylating agents in AML treatment
Molekulare Mechanismen der normalen myeloischen Differenzierung und ihrer Störung bei akuten myeloischen Leukämien
MDS und akute myeloische Leukämie : ein biologisches und therapeutisches Kontinuum
Myelodysplastic syndromes and acute myeloid leukemia : a biological and therapeutic continuum
Epigenetic therapy of cancer : preclinical models and treatment approaches
Elucidation of a hypersplicing phenotype in SRSF2 mutant myeloid malignancy
DNA-Methylierungssignaturen bei älteren Patienten mit akuter myeloischer Leukämie
Charakterisierung der antileukämischen Aktivität von drei Hydroxamat-Histondesacetylase-Inhibitoren
AML1/ETO and its function as a regulator of gene transcription via epigenetic mechanisms
Impact of pretreatment characteristics and salvage strategy on outcome in patients with relapsed acute myeloid leukemia
Condensed versus standard schedule of high-dose cytarabine consolidation therapy with pegfilgrastim growth factor support in acute myeloid leukemia
The new WHO 2022 and ICC proposals for the classification of myelodysplastic neoplasms. Validation based on the Düsseldorf MDS Registry and proposals for a merged classification